These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 12949985)

  • 61. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
    Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
    Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.
    Liu YP; Ma L; Wang SJ; Chen YN; Wu GX; Han M; Wang XL
    Eur J Surg Oncol; 2010 Feb; 36(2):155-9. PubMed ID: 19854606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution.
    Okura M; Hiranuma T; Adachi T; Ogura T; Aikawa T; Yoshioka H; Hayashido Y; Kogo M; Matsuya T
    Cancer; 1998 Mar; 82(5):804-15. PubMed ID: 9486567
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
    Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
    Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical study of lymph node metastatic pattern of thoracic esophageal squamous carcinoma].
    Xie YT; Wang SQ; Zuo Q; Huang JQ; An FS; Chen SH; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):573-4. PubMed ID: 15897141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Intra-arterial infusion chemotherapy for recurrent cervical lymph nodes after surgery in esophageal cancer].
    Ando T; Yokomori T; Taniguchi T; Iesato H; Takeyoshi I; Saito A; Kobayashi J; Owada S; Miyamoto Y; Morishita Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2411-3. PubMed ID: 1281398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinoma.
    Shimada H; Okazumi S; Matsubara H; Shiratori T; Shuto K; Akutsu Y; Nabeya Y; Hayashi H; Ochiai T
    Am J Surg; 2007 Apr; 193(4):448-52; discussion 453. PubMed ID: 17368286
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
    J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Basaloid-squamous carcinoma of the esophagus treated by preoperative chemotherapy: report of two cases.
    Koide N; Kishimoto K; Nakamura T; Igarashi J; Maezawa T; Hanazaki K; Adachi W; Amano J
    Surg Today; 2003; 33(6):444-7. PubMed ID: 12768371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Significant role of cisplatin and 5-FU combination chemotherapy for first-line intensive treatment for advanced esophageal cancer].
    Matsui S; Iwazawa T; Yano H; Tono T; Nakano Y; Kanoh T; Kinuta M; Monden T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1608-11. PubMed ID: 11707991
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
    Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
    Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
    Igaki H; Kato H; Tachimori Y; Nakanishi Y
    Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.